InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: circuitcity post# 276474

Wednesday, 05/27/2020 2:43:30 PM

Wednesday, May 27, 2020 2:43:30 PM

Post# of 425931
circ...

I have never discussed GIA with JT..I do agree JT has made mistakes and I am unhappy with the way JT is always helping himself to Amarin's money...

That said...I think some of the things that have happened to Amarin are not JT's fault..The Amarin story is beyond most peoples imagination. And would have stretched the abilities of Henry Ford or John D. Rockefeller. He did successfully complete the R-I trial which is a bigger accomplishment than any other Biotech or BP CEO in recent history..

We don't have complete information on the recent V. action...Including the Reno disaster..We don't know whether or not the two generics were interested in a settlement TEVA did settle..

If you had a better answer Amarin had for the Du decision..Then maybe you should be the CEO..I have always been surprised at all the opinions that BP is the answer to everyone's problems. I have been trading stocks for 60 years and I have been present for several takeovers..What is true is that shareholders do frequently see a wind fall..But it is not always beneficial for the company being bought out..In Vascepa's case V might become just one of the drugs and not the most important one..

If we know anything about Vascepa is it requires full time attention..A BP with its own projects might just throw up their hands and say. This is not worth it and just cut the chord...

If you are looking for a quick score then yes..Sell the company..but if you want to own shares in company that will be able to print its own money..then you want shares in Amarin..The road may not be smooth or certain..But if we prevail you will never have to own another company the rest of your life...And yes I know the road has been brutal..I've been in the company since late 2010...

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News